| Ytd | -9.86% | |
| 1y | -9.63% |
| Open | 6.74 | Prev Close | 6.79 | Low | 6.62 | High | 7.18 | Mkt Cap | 611.71M |
| Vol | 957.85K | Avg Vol | 2.56M | EPS | -2.50 | P/E | -2.78 | Forward P/E | -1.57 |
| Beta | 0.26 | Short Ratio | 1.87 | Inst. Own | 59.90% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 4.91 | 200-d Avg | 6.36 | 1yr Est | 11.13 |
VSTM News
Verastem NASDAQ: VSTM reported second-quarter 2026 net product revenue of $25.1 million from sales o
Verastem, Inc. (VSTM) Q2 2026 Earnings Call Transcript
Verastem (VSTM) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimat
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to
BOSTON--(BUSINESS WIRE)---- $VSTM #CRC--Verastem doses first patient in TARGET-D 203, a registration
Gainers Tenet Healthcare (NYSE:THC) shares rose 14.1% to $227.06 during Thursday's after-market
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to
BOSTON--(BUSINESS WIRE)---- $VSTM #CRC--Verastem doses first patient in TARGET-D 202, a registration
Seven small-cap stocks have surged as much as 123% in early July on buyouts, FDA developments, refin
Verastem (VSTM) was a big mover last session on higher-than-average trading volume. The latest trend
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to
Verastem, Inc. (VSTM) Discusses Preliminary TARGET-D 101 Data for VS-7375 in KRAS G12D Mutated Cance
BOSTON--(BUSINESS WIRE)---- $VSTM #CRC--VS-7375 (investigational KRAS G12D ON/OFF inhibitor) demonst
Verastem, Inc. is maintained at a Buy rating, driven by upcoming clinical catalysts and positive ear
Verastem, Inc. (NASDAQ:VSTM) stock is trading higher on Wednesday as the company announced positive
BOSTON--(BUSINESS WIRE)---- $VSTM #CancerResearch--Verastem Oncology announces updated results from
BOSTON--(BUSINESS WIRE)---- $VSTM #CRC--Verastem doses first patient in TARGET-D 201, a registration
BOSTON--(BUSINESS WIRE)---- $VSTM #CRC--Verastem Oncology to report progress across the VS-7375 oral
BOSTON--(BUSINESS WIRE)---- $VSTM #CRC--FDA grants Fast Track designation to VS-7375, an oral invest
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines f
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to
Shares of Big Lots, Inc. (NYSE: BIG) fell sharply during Monday’s session after the company reporte
On Friday morning, 446 companies hit new 52-week lows.
During Wednesday's trading, 517 companies set new 52-week lows.
On Tuesday, 838 companies hit new 52-week lows.
During Monday's trading, 528 companies set new 52-week lows.
Wednesday saw 127 companies set new 52-week lows.
Losers
Gainers
On Tuesday, 44 companies hit new 52-week lows.
On Thursday, 930 stocks hit new 52-week lows.
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares jumped 150% to close at $3.80 on Wednesday
On Monday, 524 stocks hit new 52-week lows.
On Wednesday, 348 companies hit new 52-week lows.
During Monday's session, 291 companies made new 52-week lows. Also check out this: Insid
During Friday's session, 445 companies made new 52-week lows.
During Wednesday's morning trading, 251 companies set new 52-week highs.
Tuesday morning saw 244 companies set new 52-week highs.
Before 10 a.m. ET Friday, 188 stocks made new 52-week highs.
Friday's morning session saw 160 companies set new 52-week highs.
Stocks That Hit 52-Week Lows On Thursday